New Power in Cancer Immunotherapy: The Rise of Chimeric Antigen Receptor Macrophage (CAR-M)

Scientists highlight the construction strategies and preclinical and clinical studies of CAR-engineered macrophages, introduce the anti-tumor mechanisms, and discuss their advantages and disadvantages compared with other CAR-engineered effector cells.